SEC Form D private-offering filing

Mati Therapeutics Inc.

Name: Mati Therapeutics Inc. - new SEC Form D private-offering filing, Austin, TX
Published: 2025-10-08

A new SEC Form D private-offering notice from Austin, TX, a $10,523,695 filer-stated offering target in Biotech. The source filing is one click away.

Mati Therapeutics Inc. site↗ Verified via SEC Form D

Develops the Evolute punctal plug drug delivery system for sustained treatment of glaucoma and other ocular diseases.

Filed 2025-10-08Filed to raise $10,523,695First money in 2025-09-30Raised so far $9,867,695HQ (as filed) Austin, TXSector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified matitherapeutics.com↗Named in the filing 5 executives & directors

Open this row on the live feed →More new filings in Texas →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.